MX2014000283A - Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal. - Google Patents
Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal.Info
- Publication number
- MX2014000283A MX2014000283A MX2014000283A MX2014000283A MX2014000283A MX 2014000283 A MX2014000283 A MX 2014000283A MX 2014000283 A MX2014000283 A MX 2014000283A MX 2014000283 A MX2014000283 A MX 2014000283A MX 2014000283 A MX2014000283 A MX 2014000283A
- Authority
- MX
- Mexico
- Prior art keywords
- renal
- prognosis
- diagnosis
- compositions
- methods
- Prior art date
Links
- 206010061481 Renal injury Diseases 0.000 title abstract 4
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000004393 prognosis Methods 0.000 title abstract 2
- 208000001647 Renal Insufficiency Diseases 0.000 title 1
- 201000006370 kidney failure Diseases 0.000 title 1
- 101710116299 Choriogonadotropin subunit beta Proteins 0.000 abstract 1
- 102100031196 Choriogonadotropin subunit beta 3 Human genes 0.000 abstract 1
- 102000005623 HSP27 Heat-Shock Proteins Human genes 0.000 abstract 1
- 108010045100 HSP27 Heat-Shock Proteins Proteins 0.000 abstract 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 abstract 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 abstract 1
- 102000003666 Placenta Growth Factor Human genes 0.000 abstract 1
- 108010082093 Placenta Growth Factor Proteins 0.000 abstract 1
- 102000021095 WAP Four-Disulfide Core Domain Protein 2 Human genes 0.000 abstract 1
- 108091002660 WAP Four-Disulfide Core Domain Protein 2 Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000000104 diagnostic biomarker Substances 0.000 abstract 1
- 208000037806 kidney injury Diseases 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 230000002438 mitochondrial effect Effects 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 239000000092 prognostic biomarker Substances 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161506038P | 2011-07-09 | 2011-07-09 | |
| PCT/US2012/045583 WO2013009573A1 (en) | 2011-07-09 | 2012-07-05 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2014000283A true MX2014000283A (es) | 2014-05-01 |
Family
ID=47506416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014000283A MX2014000283A (es) | 2011-07-09 | 2012-07-05 | Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20140171522A1 (https=) |
| EP (1) | EP2729803A4 (https=) |
| JP (1) | JP2014521088A (https=) |
| CN (1) | CN103858008B (https=) |
| AU (1) | AU2012282918A1 (https=) |
| CA (1) | CA2841880A1 (https=) |
| EA (1) | EA201490105A1 (https=) |
| MX (1) | MX2014000283A (https=) |
| WO (1) | WO2013009573A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014120569A1 (en) * | 2013-01-25 | 2014-08-07 | Beth Israel Deaconess Medical Center, Inc. | Methods and compositions for human epididymis protein-4 (he4) |
| WO2015081102A1 (en) | 2013-11-27 | 2015-06-04 | Gnubio, Inc. | Microfluidic droplet packing |
| CN104045453B (zh) * | 2014-06-11 | 2016-08-24 | 句容市鑫诚果业家庭农场 | 一种石榴专用有机肥料及其制备方法 |
| CN106536709A (zh) | 2014-06-16 | 2017-03-22 | 基纽拜奥股份有限公司 | 尺寸交替的注入到液滴中以促进分选 |
| CN104062294A (zh) * | 2014-07-11 | 2014-09-24 | 青岛千士医疗科技有限公司 | 一种支气管/肺上皮细胞线粒体损伤的检测方法 |
| CN104166003B (zh) * | 2014-08-06 | 2016-06-08 | 中国人民解放军第二军医大学 | 人附睾蛋白4在制备系统性红斑狼疮性肾病诊断试剂或试剂盒中的应用 |
| WO2016130802A1 (en) * | 2015-02-11 | 2016-08-18 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| TW201827070A (zh) * | 2016-12-19 | 2018-08-01 | 康鶴生醫科技股份有限公司 | 合成多肽、含該多肽的組合物、由其產生的抗體及其用途 |
| CN121186383B (zh) * | 2025-11-24 | 2026-03-13 | 华中科技大学 | 慢性肾病的蛋白质标志物的筛选及应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001016354A1 (en) * | 1999-09-02 | 2001-03-08 | Gene Logic, Inc. | Modulation of he4 in inflammatory and renal diseases |
| CN1791797A (zh) * | 2003-03-27 | 2006-06-21 | 儿童医院医疗中心 | 用于检测肾小管细胞损伤的早发的方法和试剂盒 |
| US7588892B2 (en) * | 2004-07-19 | 2009-09-15 | Entelos, Inc. | Reagent sets and gene signatures for renal tubule injury |
| US20070087387A1 (en) * | 2005-04-21 | 2007-04-19 | Prasad Devarajan | Method for the Early Detection of Renal Disease Using Proteomics |
| WO2008060607A2 (en) * | 2006-11-14 | 2008-05-22 | Biosite Incorporated | Methods and compositions for monitoring and risk prediction in cardiorenal syndrome |
| CN101802014A (zh) * | 2007-03-09 | 2010-08-11 | 三路影像公司 | He4单克隆抗体和它们的使用方法 |
| EP2479569A3 (en) * | 2007-03-26 | 2012-09-26 | Novartis AG | Predictive renal safety biomarkers and biomarker signatures to monitor kidney function |
| KR20100122495A (ko) * | 2008-02-29 | 2010-11-22 | 고쿠리츠 다이가쿠 호우징 나고야 다이가쿠 | 급성 신장 장해 및 예후 추정용 바이오마커 및 그 용도 |
| WO2009126380A2 (en) * | 2008-03-05 | 2009-10-15 | Singulex, Inc. | Methods and compositions for highly sensitive detection of molecules |
| CA2726563A1 (en) * | 2008-06-04 | 2009-12-10 | Proteosys Ag | Protein biomarkers for in vitro testing of developmental toxicity and embryotoxicity of chemical substances |
| JP2012501456A (ja) * | 2008-08-28 | 2012-01-19 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後のための方法および組成物 |
| AU2009316387B2 (en) * | 2008-11-22 | 2015-01-29 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2011075744A1 (en) * | 2009-12-20 | 2011-06-23 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| WO2011109830A2 (en) * | 2010-03-05 | 2011-09-09 | Case Western Reserve University | Protein biomarkers and therapeutic targets for renal disorders |
| WO2012074888A2 (en) * | 2010-11-29 | 2012-06-07 | Alere San Diego, Inc. | Methods and compositions for diagnosis and risk prediction in heart failure |
| WO2013006629A1 (en) * | 2011-07-06 | 2013-01-10 | Alere San Diego Inc. | Methods and compositions for assigning likelihood of acute kidney injury progression |
-
2012
- 2012-07-05 US US14/131,678 patent/US20140171522A1/en not_active Abandoned
- 2012-07-05 MX MX2014000283A patent/MX2014000283A/es not_active Application Discontinuation
- 2012-07-05 AU AU2012282918A patent/AU2012282918A1/en not_active Abandoned
- 2012-07-05 WO PCT/US2012/045583 patent/WO2013009573A1/en not_active Ceased
- 2012-07-05 EP EP12810709.1A patent/EP2729803A4/en not_active Withdrawn
- 2012-07-05 CA CA2841880A patent/CA2841880A1/en not_active Abandoned
- 2012-07-05 JP JP2014520221A patent/JP2014521088A/ja active Pending
- 2012-07-05 EA EA201490105A patent/EA201490105A1/ru unknown
- 2012-07-05 CN CN201280039959.5A patent/CN103858008B/zh not_active Expired - Fee Related
-
2015
- 2015-12-09 US US14/964,410 patent/US20160097779A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN103858008B (zh) | 2017-03-01 |
| AU2012282918A1 (en) | 2014-02-06 |
| EP2729803A4 (en) | 2015-08-05 |
| US20140171522A1 (en) | 2014-06-19 |
| US20160097779A1 (en) | 2016-04-07 |
| CA2841880A1 (en) | 2013-01-17 |
| CN103858008A (zh) | 2014-06-11 |
| WO2013009573A1 (en) | 2013-01-17 |
| EA201490105A1 (ru) | 2014-07-30 |
| JP2014521088A (ja) | 2014-08-25 |
| EP2729803A1 (en) | 2014-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2014000283A (es) | Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal. | |
| WO2011106746A1 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| EA201290629A1 (ru) | Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности | |
| MX2012001559A (es) | Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal. | |
| EP2767833A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX341926B (es) | Metodos y composiciones para la diagnosis y prognosis de daño renal y falla renal. | |
| EP3734280A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX346096B (es) | Métodos y composiciones para diagnóstico y pronóstico de lesión renal e insuficiencia renal. | |
| NZ625423A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX2011008323A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. | |
| NZ608316A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| NZ630277A (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| WO2009083950A3 (en) | Biomarkers for the prediction of renal injury | |
| EP2585826A4 (en) | METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE | |
| MX388231B (es) | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal. | |
| MX2019008260A (es) | Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c. | |
| MX339765B (es) | Metodos y composiciones para diagnostico y pronostico de lesion renal y falla renal. | |
| WO2012094658A3 (en) | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | |
| MX2012005218A (es) | Metodos y composiciones para el diagnostico y pronostico de daño renal y falla renal. | |
| MX2012003168A (es) | Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal. | |
| WO2013066879A3 (en) | SOLUBLE UROKINASE RECEPTOR (suPAR) IN DIABETIC KIDNEY DISEASE | |
| WO2014187884A3 (en) | Mirnas as non-invasive biomarkers for heart failure | |
| WO2012089753A3 (en) | Complex sets of mirnas as non-invasive biomarkers for glioblastoma | |
| BR112015009993A2 (pt) | método baseado em local de usuário selt para detectar a presença de um microfiltro em uma conexão vdsl | |
| IN2014MN01759A (https=) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |